Pages that link to "Q37038629"
Jump to navigation
Jump to search
The following pages link to The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas (Q37038629):
Displaying 50 items.
- Bayesian non-negative factor analysis for reconstructing transcription factor mediated regulatory networks (Q21093269) (← links)
- ZNF703 gene amplification at 8p12 specifies luminal B breast cancer (Q24293333) (← links)
- Comprehensive molecular portraits of human breast tumours (Q24630844) (← links)
- Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies (Q26750380) (← links)
- The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis (Q26865888) (← links)
- Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions (Q27022834) (← links)
- Post-transcriptional gene expression control by NANOS is up-regulated and functionally important in pRb-deficient cells (Q28118300) (← links)
- Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis (Q28280822) (← links)
- Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer (Q28372484) (← links)
- Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer (Q29619481) (← links)
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers (Q29619914) (← links)
- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status (Q30496322) (← links)
- A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer (Q30587056) (← links)
- Web-based interrogation of gene expression signatures using EXALT. (Q33518013) (← links)
- Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System (Q33668830) (← links)
- Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts (Q33742688) (← links)
- Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures. (Q33788520) (← links)
- Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival (Q33868774) (← links)
- Differential expression pattern-based prioritization of candidate genes through integrating disease-specific expression data (Q33880471) (← links)
- αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation (Q33932784) (← links)
- p16INK4a expression in basal-like breast carcinoma. (Q34007463) (← links)
- Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers (Q34013967) (← links)
- Coregulation of FANCA and BRCA1 in human cells (Q34084861) (← links)
- The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer (Q34115095) (← links)
- Molecular insights on basal-like breast cancer (Q34123314) (← links)
- The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. (Q34134278) (← links)
- The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments (Q34202289) (← links)
- ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2 (Q34316094) (← links)
- A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers (Q34456552) (← links)
- Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution (Q34485060) (← links)
- Targeting breast cancer stem cells (Q34505105) (← links)
- Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer (Q34532230) (← links)
- Hippo pathway mediates resistance to cytotoxic drugs (Q34555337) (← links)
- Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies (Q34562257) (← links)
- Systems biology and genomics of breast cancer (Q34576377) (← links)
- Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. (Q34610562) (← links)
- Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients. (Q34659119) (← links)
- RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response (Q34659897) (← links)
- Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers (Q34854816) (← links)
- An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer (Q34989075) (← links)
- Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer (Q35010102) (← links)
- Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy (Q35020412) (← links)
- P16 and p53 play distinct roles in different subtypes of breast cancer (Q35022751) (← links)
- RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs (Q35050328) (← links)
- CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer (Q35064727) (← links)
- RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer (Q35157633) (← links)
- Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment (Q35168174) (← links)
- p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia (Q35597120) (← links)
- β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib (Q35608736) (← links)
- RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer (Q35620241) (← links)